Our data demonstrated in T-ALL microenvironment, MSCs secreted amounts of FGF2, which bind to FGFR2 on T-ALL cells, leading to the activation of PI3K/Akt/mTOR pathway of T-ALL cells. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.